Capricor Therapeutics
CAPR
CAPR
7 hedge funds and large institutions have $5.36M invested in Capricor Therapeutics in 2015 Q1 according to their latest regulatory filings, with 7 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
Holders
7
Holders Change
+7
Holders Change %
–
% of All Funds
0.19%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
7
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
BC
1
Broadfin Capital
New York
|
$4.87M |
| 2 |
2
Morgan Stanley
New York
|
$249K |
| 3 |
3
Millennium Management
New York
|
$160K |
| 4 |
PA
4
Perceptive Advisors
New York
|
$35K |
| 5 |
CFN
5
Cordasco Financial Network
Naples,
Florida
|
$27K |
Top Sellers
No sellers this quarter
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
BC
1
Broadfin Capital
New York
| $4.87M | 705,882 | +705,882 | New |
|
|
2
Morgan Stanley
New York
| $249K | 28,875 | +28,875 | New |
|
|
3
Millennium Management
New York
| $160K | 18,570 | +18,570 | New |
|
|
PA
4
Perceptive Advisors
New York
| $35K | 4,000 | +4,000 | New |
|
|
CFN
5
Cordasco Financial Network
Naples,
Florida
| $27K | 3,100 | +3,100 | New |
|
6
UBS Group
Zurich,
Switzerland
| $17K | 2,000 | +2,000 | New |
|
|
TRCT
7
Tower Research Capital (TRC)
New York
| $0 | 22 | +22 | New |
|